All questionsPharmacology: Stelara (ustekinumab), all indications3 questions · 2 sourcesMechanismHow does Stelara work (mechanism of action)?“STELARA® is a human IgG1k monoclonal antibody that binds with specificity to the p40 protein subunit used by both the interleukin (IL)-12 and IL-23 cytokines1 IL-12 and IL-23 are naturally occurring cytokines that are involved in inflammatory and immune responses, such as natural killer cell activation and CD4+ T-cell differentiation and activation1 In in vitro models, STELARA® was shown to disrupt IL-12– and IL-23–mediated signaling and cytokine cascades by disrupting the interaction of these cytokines with a shared cell-surface receptor chain, IL-12Rβ11 The clinical significance of these characteristics is not fully known” (opens the source at this quote in a new tab)CopyFlagPharmacokineticsHow is Stelara metabolized?“The metabolic pathway of ustekinumab has not been characterized. As a human IgG1κ monoclonal antibody, ustekinumab is expected to be degraded into small peptides and amino acids via catabolic pathways in the same manner as endogenous IgG.” (opens the source at this quote in a new tab)CopyFlagComponentsDoes the Stelara prefilled syringe contain latex?“The needle cover on the prefilled syringe contains dry natural rubber (a derivative of latex). The needle cover should not be handled by persons sensitive to latex.” (opens the source at this quote in a new tab)CopyFlag